IJMS, Vol. 24, Pages 6628: Blood–Brain Barrier Biomarkers before and after Kidney Transplantation

1 year ago 45

IJMS, Vol. 24, Pages 6628: Blood–Brain Barrier Biomarkers before and after Kidney Transplantation

International Journal of Molecular Sciences doi: 10.3390/ijms24076628

Authors: Leah Hernandez Liam J. Ward Samsul Arefin Peter Barany Lars Wennberg Magnus Söderberg Stefania Bruno Vincenzo Cantaluppi Peter Stenvinkel Karolina Kublickiene

Kidney transplantation (KT) may improve the neurological status of chronic kidney disease (CKD) patients, reflected by the altered levels of circulating BBB-specific biomarkers. This study compares the levels of neuron specific enolase (NSE), brain-derived neurotrophic factor (BDNF), neurofilament light chain (NfL), and circulating plasma extracellular vesicles (EVs) in kidney-failure patients before KT and at a two-year follow up. Using ELISA, NSE, BDNF, and NfL levels were measured in the plasma of 74 living-donor KT patients. Plasma EVs were isolated with ultracentrifugation, and characterized for concentration/size and surface protein expression using flow cytometry from a subset of 25 patients. Lower NSE levels, and higher BDNF and NfL were observed at the two-year follow-up compared to the baseline (p < 0.05). Male patients had significantly higher BDNF levels compared to those of females. BBB biomarkers correlated with the baseline lipid profile and with glucose, vitamin D, and inflammation markers after KT. BBB surrogate marker changes in the microcirculation of early vascular aging phenotype patients with calcification and/or fibrosis were observed only in NSE and BDNF. CD31+ microparticles from endothelial cells expressing inflammatory markers such as CD40 and integrins were significantly reduced after KT. KT may, thus, improve the neurological status of CKD patients, as reflected by changes in BBB-specific biomarkers.

Read Entire Article